4-Methylmorpholine → (3S)-ethyl 3-[[4-[[4-(aminoiminomethyl)phenyl]amino]-1,4-dioxobutyl]amino]-4-pentynoate

HRID 1781127Notizen

Reaktionsgleichung

Reaktionsgleichung von HRID 1781127
Cl.[NH2:2][N:3]=[CH:4][C:5]1[CH:10]=[CH:9][C:8]([NH:11][C:12](=[O:18])[CH2:13][CH2:14][C:15]([OH:17])=O)=[CH:7][CH:6]=1.CN1CCOCC1.ClC(OCC(C)C)=O.[NH2:34][C@H:35]([C:42]#[CH:43])[CH2:36][C:37]([O:39][CH2:40][CH3:41])=[O:38].C(N(C(C)C)CC)(C)C.CN(C1C=CC=CN=1)C>CN(C=O)C>[NH2:2][N:3]=[CH:4][C:5]1[CH:6]=[CH:7][C:8]([NH:11][C:12](=[O:18])[CH2:13][CH2:14][C:15]([NH:34][C@H:35]([C:42]#[CH:43])[CH2:36][C:37]([O:39][CH2:40][CH3:41])=[O:38])=[O:17])=[CH:9][CH:10]=1

Komponenten

8

Versuchsvorschrift

4-[[4-(Aminoiminomethyl)phenyl]amino]-4-oxobutanoic acid hydrochloride was added to dry DMF (35 ml) followed by N-methylmorpholine (0.39 g, 1 eq.) and isobutyl chloroformate (0.53 g, 3.9 mmol) at 25° C. The mixture was stirred for 5 min. (S)-ethyl 3-amino-4-pentynoate was added followed by diisopropylethylamine and a catalytic amount of dimethylaminopyridine. After 1 hour, the solvent was removed under reduced pressure and the product was purified by reverse phase chromatography to give (3S)-ethyl 3-[[4-[[4-(aminoiminomethyl)phenyl]amino]-1,4-dioxobutyl]amino]-4-pentynoate.

Aufarbeitung

  1. additionwas added
  2. customthe solvent was removed under reduced pressure
  3. customthe product was purified by reverse phase chromatography

Quellen und Nachweise

ORD-Eintrag
ord-5a6738c6e3e64ced845e39bbb9e836f6
Quelldatensatz
uspto-grants-1997_05
Patentnummer
US05631399

Notizen zur Reaktion

Wird geladen…